“…Although the use of MSCs is a common cell source for tissue engineering applications (Aslam et al, 2020; Ekram et al, 2021; Khalid et al, 2022; Sahibdad et al, 2023; Zhao et al, 2018), these cells can self‐renew, survive, and differentiation is highly dependent on the ECM that surrounds them (Khan et al, 2022; Sundaram et al, 2018). Human UC‐derived MSCs provide many advantages over other stem cell sources, including easier access, improved osteochondral differentiation in comparison to other stem cell sources, fewer ethical concerns, and proliferative potency (Basiri et al, 2019; Vautrin‐Glabik et al, 2020).…”